Patents by Inventor George A. Nickols

George A. Nickols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha v beta 3 integrin antagonists in combination with chemotherapeutic agents
    Publication number: 20030050250
    Abstract: The present invention is directed to compounds of the formula 1
    Type: Application
    Filed: December 10, 2001
    Publication date: March 13, 2003
    Inventors: Jay Cunningham, Gary B. Gordon, George A. Nickols, William F. Westlin, Thomas E. Rogers, Peter G. Ruminski
  • Methods for using anti-&agr;v&bgr;3 integrin antibody
    Patent number: 6193968
    Abstract: Monoclonal antibodies that recognize the &agr;v&bgr;3 integrin receptor complex, but do not significantly bind to &agr;IIb&bgr;IIIa, can be used in methods for treating &agr;v&bgr;3 integrin-mediated diseases, such as tunor metastasis.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: February 27, 2001
    Assignees: The Burnham Institute, G. D. Searle & Company
    Inventors: Christopher P. Carron, Debra M. Meyer, George A. Nickols, Jeffrey W. Smith
  • Anti-&agr;v&bgr;3 integrin antibody antagonists
    Patent number: 6171588
    Abstract: Monoclonal antibodies that recognize the &agr;v &bgr;3 integrin receptor complex, but do not significantly bind to &agr;IIb&bgr;IIIa, inhibit &agr;v&bgr;3 integrin-mediated diseases.
    Type: Grant
    Filed: April 9, 1998
    Date of Patent: January 9, 2001
    Assignee: G. D. Searle & Company
    Inventors: Christopher P. Carron, Debra M. Meyer, George A. Nickols